» Articles » PMID: 25474108

Crushed and Injected Buprenorphine Tablets: Characteristics of Princeps and Generic Solutions

Overview
Journal PLoS One
Date 2014 Dec 5
PMID 25474108
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Self-injection of high-dose buprenorphine is responsible for well-described complications. In 2011, we have been alerted by unusual but serious cutaneous complication among injection buprenorphine users. A prospective data collection identified 30 cases of necrotic cutaneous lesions after injection of filtered buprenorphine solution, among which 25 cases occurred following injection of buprenorphine generics. The main goal of our study was to put forward particularities that could explain the cutaneous complications, by qualitatively and quantitatively confronting particles present in Subutex and generics solutions. We used the same protocol that injected-buprenorphine users: generic or subutex tablets were crushed in sterile water and filtered through 2 filters commonly used (cotton-pad and sterifilt). Solutions were analyzed by laser granulometry, flow cytometry and scanning electron microscopy. We have highlighted the wide variation of the quantity and the size of the particles present in solution between the two drugs after cotton-pad filtration. The proportion of particles <10 µm is systematically higher in the generic solutions than with Subutex. All of the insoluble particles found in generic solutions contain silica, whereas non- organic element was to be identified in the insoluble particles of Subutex. One skin biopsy obtained from one patient who developed a necrotic lesion after intravenous injection of filtrated solution of buprenorphine generic, shows non-organic elements. Identification of particles in situ enables us to confirm the presence of silica in the biopsy. Actually the monitoring of patient receiving generic of buprenorphine must be strengthened.

Citing Articles

Intravenous misuse of slow-release oral morphine capsules: how much morphine is injected?.

Bertin C, Montigne E, Teixeira S, Ferrer F, Lauwerie L, Richard D Harm Reduct J. 2023; 20(1):59.

PMID: 37106464 PMC: 10134660. DOI: 10.1186/s12954-023-00781-2.


Crushed it: Elucidation of systemic vasculitis caused by injected hydromorphone tablets via skin biopsy.

Rolader R, Bishop B, Eyre Z, Cheeley J JAAD Case Rep. 2019; 5(10):906-908.

PMID: 31649979 PMC: 6804559. DOI: 10.1016/j.jdcr.2019.08.016.


Is thrombotic event a side effect of oral buprenorphine abuse? Two case reports.

Alirezaei T, Hajimoradi B Clin Case Rep. 2019; 7(4):740-743.

PMID: 30997076 PMC: 6452464. DOI: 10.1002/ccr3.2086.


Livedoid Dermatitis Treated With Nifedipine.

Wheless L, Zhu L, Mashayekhi M, Fissell R J Investig Med High Impact Case Rep. 2016; 4(1):2324709616629786.

PMID: 26885536 PMC: 4740942. DOI: 10.1177/2324709616629786.

References
1.
Corazza M, Capozzi O, Virgilit A . Five cases of livedo-like dermatitis (Nicolau's syndrome) due to bismuth salts and various other non-steroidal anti-inflammatory drugs. J Eur Acad Dermatol Venereol. 2002; 15(6):585-8. DOI: 10.1046/j.1468-3083.2001.00320.x. View

2.
Hornez E, Laroche J, Monchal T, Bourgouin S, Riviere P, Fournier R . [Necrosis of the glans penis: a complication of an injection of buprenorphin in a opioid abuser]. Ann Chir Plast Esthet. 2009; 55(2):159-61. DOI: 10.1016/j.anplas.2008.12.004. View

3.
Davis N, Turco S, Sivelly E . A study of particulate matter in I.V. infusion fluids. Am J Hosp Pharm. 1970; 27(10):822-6. View

4.
Bellot B, Bonnet C, Retornaz K, Panuel M, Garnier J, Dubus J . [Nicolau syndrome after intramuscular injection]. Arch Pediatr. 2014; 21(4):377-80. DOI: 10.1016/j.arcped.2014.01.016. View

5.
Grau D, Vidal N, Faucherre V, Leglise Y, Pinzani V, Blayac J . [Infectious adverse events related to misuse of high-dose buprenorphine: a retrospective study of 42 cases]. Rev Med Interne. 2010; 31(3):188-93. DOI: 10.1016/j.revmed.2009.10.433. View